• Je něco špatně v tomto záznamu ?

Hemodynamic and white blood cells parameters in patients with first-episode psychosis: a pilot longitudinal study

L. Ustohal, M. Mayerova, K. Horska, M. Obdrzalkova, H. Crhova, H. Prikrylova Kucerova, E. Ceskova, T. Kasparek

. 2022 ; 26 (2) : 213-216. [pub] 20210810

Jazyk angličtina Země Anglie, Velká Británie

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc22025433

OBJECTIVE: Patients with schizophrenia are at higher risk of cardiovascular (CVS) related mortality. Close attention is being paid to the clinical utility of readily available CVS markers. METHODS: A pilot one-year longitudinal study in inpatients with first-episode psychosis (FEP) was carried out to determine markers of inflammation and endothelial dysfunction (monocyte- and neutrophil-to-lymphocyte ratios) and basal blood pressure, pulse, and derived hemodynamic parameters (PP: pulse pressure; RPP: rate pressure product; and MAP: mean arterial pressure). RESULTS: After one year, PP and RPP increased, as did systolic blood pressure and heart rate. Systolic blood pressure, PP, total white blood cells, and neutrophils correlated with weight gain. After one year, correlations between monocyte-to-lymphocyte ratio and RPP and MAP were observed. CONCLUSION: Our study indicates worsening CVS health over the first year of treatment and emphasises the importance of early monitoring of CVS status using easily accessible parameters to prevent CVS-related mortality.Key pointsPatients with schizophrenia are at higher risk of cardiovascular mortality.The CVS risk could be evaluated using affordable, routinely available CVS markers such as monocyte- and neutrophil-to-lymphocyte ratios, blood pressure, and pulse together with the derived parameters.Our pilot study in first-episode psychosis patients indicates worsening of CVS health based on these parameters during the first year of treatment, the early monitoring of CVS status is highly relevant in clinical practice.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22025433
003      
CZ-PrNML
005      
20221031100147.0
007      
ta
008      
221017s2022 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1080/13651501.2021.1962357 $2 doi
035    __
$a (PubMed)34375167
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Ustohal, Libor $u Department of Psychiatry, University Hospital Brno and Faculty of Medicine Masaryk University, Brno, Czech Republic $u Department of Pharmacology and Toxicology, Faculty of Pharmacy, Masaryk University, Brno, Czech Republic
245    10
$a Hemodynamic and white blood cells parameters in patients with first-episode psychosis: a pilot longitudinal study / $c L. Ustohal, M. Mayerova, K. Horska, M. Obdrzalkova, H. Crhova, H. Prikrylova Kucerova, E. Ceskova, T. Kasparek
520    9_
$a OBJECTIVE: Patients with schizophrenia are at higher risk of cardiovascular (CVS) related mortality. Close attention is being paid to the clinical utility of readily available CVS markers. METHODS: A pilot one-year longitudinal study in inpatients with first-episode psychosis (FEP) was carried out to determine markers of inflammation and endothelial dysfunction (monocyte- and neutrophil-to-lymphocyte ratios) and basal blood pressure, pulse, and derived hemodynamic parameters (PP: pulse pressure; RPP: rate pressure product; and MAP: mean arterial pressure). RESULTS: After one year, PP and RPP increased, as did systolic blood pressure and heart rate. Systolic blood pressure, PP, total white blood cells, and neutrophils correlated with weight gain. After one year, correlations between monocyte-to-lymphocyte ratio and RPP and MAP were observed. CONCLUSION: Our study indicates worsening CVS health over the first year of treatment and emphasises the importance of early monitoring of CVS status using easily accessible parameters to prevent CVS-related mortality.Key pointsPatients with schizophrenia are at higher risk of cardiovascular mortality.The CVS risk could be evaluated using affordable, routinely available CVS markers such as monocyte- and neutrophil-to-lymphocyte ratios, blood pressure, and pulse together with the derived parameters.Our pilot study in first-episode psychosis patients indicates worsening of CVS health based on these parameters during the first year of treatment, the early monitoring of CVS status is highly relevant in clinical practice.
650    _2
$a biologické markery $7 D015415
650    _2
$a krevní tlak $7 D001794
650    _2
$a hemodynamika $7 D006439
650    _2
$a lidé $7 D006801
650    _2
$a longitudinální studie $7 D008137
650    _2
$a neutrofily $7 D009504
650    _2
$a pilotní projekty $7 D010865
650    12
$a psychotické poruchy $7 D011618
655    _2
$a časopisecké články $7 D016428
700    1_
$a Mayerova, Michaela $u Department of Psychiatry, University Hospital Brno and Faculty of Medicine Masaryk University, Brno, Czech Republic
700    1_
$a Horska, Katerina $u Department of Psychiatry, University Hospital Brno and Faculty of Medicine Masaryk University, Brno, Czech Republic $u Department of Pharmacology and Toxicology, Faculty of Pharmacy, Masaryk University, Brno, Czech Republic $u Department of Clinical Pharmacy, University Hospital Brno, Brno, Czech Republic
700    1_
$a Obdrzalkova, Marie $u Department of Psychiatry, University Hospital Brno and Faculty of Medicine Masaryk University, Brno, Czech Republic
700    1_
$a Crhova, Hana $u Department of Psychiatry, University Hospital Brno and Faculty of Medicine Masaryk University, Brno, Czech Republic
700    1_
$a Prikrylova Kucerova, Hana $u Department of Psychology, Faculty of Philosophy, Masaryk University, Brno, Czech Republic
700    1_
$a Ceskova, Eva $u Department of Psychiatry, University Hospital Brno and Faculty of Medicine Masaryk University, Brno, Czech Republic
700    1_
$a Kasparek, Tomas $u Department of Psychiatry, University Hospital Brno and Faculty of Medicine Masaryk University, Brno, Czech Republic
773    0_
$w MED00006348 $t International journal of psychiatry in clinical practice $x 1471-1788 $g Roč. 26, č. 2 (2022), s. 213-216
856    41
$u https://pubmed.ncbi.nlm.nih.gov/34375167 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20221017 $b ABA008
991    __
$a 20221031100145 $b ABA008
999    __
$a ok $b bmc $g 1854915 $s 1176723
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2022 $b 26 $c 2 $d 213-216 $e 20210810 $i 1471-1788 $m International journal of psychiatry in clinical practice $n Int. j. psychiatry clin. pract.(Print) $x MED00006348
LZP    __
$a Pubmed-20221017

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé

Možnosti archivace

Nahrávání dat ...